(CNN) — In a Phase 1/2 clinical trial, Moderna’s combination vaccine appeared to elicit “strong” immune responses against both influenza and Covid-19 and was found to<a class="excerpt-read-more" href="https://whdh.com/news/modernas-flu-covid-combo-vaccine-elicits-strong-immune-response-in-phase-1-2-study-company-says/">Read More</a>
Related Keywords
Archana Chatterjee , Pfizer , Rosalind Franklin University , Cnn , Chicago Medical School ,
comparemela.com © 2020. All Rights Reserved.